Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BTCS Inc. Capital/Financing Update 2016

Jul 13, 2016

33585_rns_2016-07-13_e430e30d-8081-41fd-a338-734ce1343c88.zip

Capital/Financing Update

Open in viewer

Opens in your device viewer

8-K 1 form8-k.htm

Field: Rule-Page

Field: /Rule-Page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 8, 2016

BTCS Inc.

(Exact Name of Registrant as Specified in Charter)

Nevada 000-55141 90-1096644
(State
or other jurisdiction of
incorporation) (Commission File
Number) (IRS
Employer Identification
No.)

| 1901 N Moore St, Suite 700 Arlington,

VA 22209
(Address
of principal executive offices) (Zip
Code)

Registrant’s telephone number, including area code: (248) 764-1084

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 DFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4(c))

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

Item 3.02 Unregistered Sales of Equity Securities.

Over the course of July 6, 2016 through July 12, 2016, BTCS Inc. (the “Company”) issued a total of 103,731,986 shares of the Company’s common stock (the “Common Stock”) for: i) the conversion of $199,185 of principal and accrued interest on the Senior Secured Convertible Notes issued December 16, 2015 (the “Notes”), and ii) the exercise of warrants. The issuances were exempt from registration pursuant to Rule 506 under Regulation D, the investors are sophisticated and familiar with our operations, and there was no solicitation in connection with the issuances. The dates of the issuances and the numbers of shares issued are as follows:

Date Note Conversions Issued — Warrant Exercises Total
July 6, 2016 13,107,365 7,500,000 20,607,365
July 7, 2016 32,997,387 40,935,845 73,933,232
July 8, 2016 28,313,307 35,380,676 63,693,983
July 11, 2016 43,015,180 36,502,280 79,517,460
July 12, 2016 8,214,526 16,000,000 24,214,526
Total Issued Shares 125,647,765 136,318,801 103,731,986

None of the securities were sold through an underwriter and accordingly, there were no underwriting discounts or commissions involved. No registration rights were granted to any of the purchasers. Following these issuances, there were 510,459,666 shares of our Common Stock issued and outstanding.

As a result of the Note conversions, the Company became obligated to issue, subject to certain limitations, the following additional securities: (i) 3,507,833,471 shares of Common Stock pursuant to “favored nations” provisions in certain common stockholder subscription agreements; and (ii) warrants to purchase 1,703,544,009 shares of Common Stock pursuant to “favored nations” provisions in certain common stockholder subscription agreements. These figures do not reflect additional warrants to purchase Common Stock issuable to certain investors pursuant to the terms of the warrants issued on December 16, 2016 as a result of the cashless exercise of warrants resulting in the issuance of 136,318,801 shares of Common Stock as detailed in the table above and as reflected on the Company’s Current Report filed on Form 8k on June 22, 2016. The Company must also lower the conversion price of the Company’s outstanding junior and senior convertible notes to $0.00078. The Company does not currently have sufficient authorized and unreserved shares to fulfill its obligations with respect to the issuance of new shares of Common Stock. While no assurances can be made, the Company intends to seek shareholder approval to adjust the Company’s capitalization.

Field: Page; Sequence: 2

Field: /Page

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

| /s/

Charles W. Allen
Charles
W. Allen
Chief
Executive Officer

Field: Page; Sequence: 3

Field: /Page